About Fermentalg
Fermentalg is a publicly listed company based in Libourne (France) founded in 2005. It operates as a microalgae are processed via fermentors to yield biomass feedstock. It operates in the Healthcare, Agriculture, and Environment sectors. Fermentalg has raised $30.3 million across 5 funding rounds from investors including Bpifrance, NextStage AM and Galia Gestion. The company has 64 employees. Fermentalg offers products and services including Vegan Omega 3, Natural Colors, Natural Antioxidants, Proteins for Aquafeed, and Proteins for Petfood. Its focus areas include Environment Tech, Air Pollution Management Tech, Carbon Management and Carbon Capture. Its competitors include GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
Fermentalg was founded in 2005 in Libourne, France, within the biotechnology sector focused on microalgae cultivation. Biomass is produced through proprietary fermentation processes for applications in animal feed, human nutrition, and energy production. Twenty-six patents have been filed for these methods, and operations include over 30 fermenters with capacities ranging from 1 to 750 liters.
- Headquarters Libourne, France
- Employees 64
- Stage Public
- SectorsHealthcareAgriculture Environment
- Website fermentalg.com
- Social LinkedIn X
- Legal Name Fermentalg Sa
- Annual Revenue$15.72 M (USD)16.41as on Dec 31, 2025
- Net Profit-$11.09 M (USD)26.71as on Dec 31, 2025
- EBITDA-$9.44 M (USD)2.11as on Dec 31, 2025
- Total Equity Funding$30.3M (USD)
in 5 rounds
- InvestorsBpifrance
& 9 more
- Employee Count64
Products & Services of Fermentalg
Fermentalg offers a comprehensive portfolio of products and services, including Vegan Omega 3, Natural Colors, Natural Antioxidants, Proteins for Aquafeed, and Proteins for Petfood.
Algae-derived omega 3 for vegan dietary and health needs.
Pigments from microalgae for natural food coloring applications.
Antioxidants sourced from algae for preservation and wellness.
Proteins for sustainable fish and aquaculture feed options.
Proteins for high-quality petfood and animal health products.
Funding Insights of Fermentalg
Fermentalg has successfully raised a total of $30.3M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30.3M
- Total Rounds 5
- First Round $7.21M
(Jan 2011)
- Investors Count 10
All 5 funding rounds of Fermentalg with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | – | Post-IPO | – | – | |
| Apr 2014 | $55.8M | Post-IPO | – | – | |
| Sep 2013 | $16.23M | Series B | – | Smalt Capital, Bpifrance | |
| Jun 2011 | $6.86M | Series B | – | Demeter | – |
| Jan 2011 | $7.21M | Series A | – | Ace Management, Picoty | – |
10 investors in total: 10 institutional.
Investors in Fermentalg
Fermentalg has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, NextStage AM and Galia Gestion.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
NextStage AM is recognized as a pioneer in capital development. | 2002 | nextstage-am.com | Paris, France | |
Galia Gestion is engaged in private equity investments in southwestern France. | – | galia-gestion.com | Bordeaux, France | |
Smalt Capital is engaged in capital investment and renewable energy financing. | 2000 | smaltcapital.com | Marseille, France | |
Demeter is recognized as a major European investor in venture capital and private equity for energy and ecological transition. | – | demeter-im.com | Paris, France | |
Investments in startups are facilitated to valorize CEA technologies. | 1999 | cea-investissement.com | France | |
- | – | sofiproteol.com | - | |
- | – | acemanagement.com | - | |
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France | |
- | – | picoty.fr | - | |
- | – | fineo-aquitaine.fr | - |
Investor details for Fermentalg
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fermentalg
17 people are tracked at Fermentalg (8 in leadership, 9 in team); the tracked headcount is 64.
| Name | Role | Group |
|---|---|---|
Philippe Lavielle | Chairman & CEO | Leadership |
Bertrand Devillers | Chief Financial Officer | Leadership |
Hywel Griffiths | Directeur Scientifique/chief Scientist | Leadership |
Manuel Rodrigo Rangel | R&d Director | Leadership |
Alfonso Moreda Cantero | Global Sales And Marketing Director | Leadership |
Emmanuelle Benitez Cano | Human Resources Director | Leadership |
Nico Bonne | Chief Commercial Officer | Leadership |
Marie Jane Fallourd | Director Pigments & Functional Proteins Unit | Leadership |
Alexia Renard | Product Manager | Team |
Adeline Lapendrie | Process Development Manager | Team |
Olivier Cagnac | Extraction & Purification Manager | Team |
Maxime Jarret | Ingénieur Junior Microbiologie | Team |
Colleen Raffin | Industrialization And Continuous Improvement Engineer | Team |
Lucie Lingrand | Chef De Produits | Team |
Christine Bousses | Analytical Development & QC Manager | Team |
Coralie Lefebvre | Fermentation Manager | Team |
Guillaume Nogaro | Site and Supply Chain Manager | Team |
Complete people profiles for Fermentalg
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Fermentalg
Fermentalg is a publicly listed company on the EURONEXT with ticker symbol ALGAE in France, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Apr 2014
- Listed onEuronext: FALG
- Listed entityFermentalg SA
- Exchange sectorConsumer non-durables
- ISINFR0011271600
- Share price0.40 EUR (-3.14% on the day) · 2026-10-14
- Market capitalisation49,604,666.00 EUR
- EPS (diluted, trailing year)-0.09 EUR
- Volume (last session)55,472
Financials of Fermentalg
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 13.4M EUR | -9.4M EUR | -8.0M EUR |
| 2024 | 11.5M EUR | -12.9M EUR | -8.2M EUR |
| 2023 | 4.1M EUR | -14.2M EUR | -9.4M EUR |
| 2022 | 7.7M EUR | -9.9M EUR | -7.6M EUR |
| 2021 | 5.7M EUR | -6.8M EUR | -7.0M EUR |
Detailed financial statements for Fermentalg
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Fermentalg
4 dated milestones of Fermentalg across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Fermentalg is founded.
- Funding First funding round of $7.2M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO,.
Competitors of Fermentalg
Fermentalg has 10 listed competitors in our database, 9 of them funded. They include GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed competitors of Fermentalg
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fermentalg
The website of Fermentalg (fermentalg.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 18% vs previous month
Websites whose visitors overlap most with Fermentalg. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
formule-verte.com | formule-verte.com | 100% | – | – | – |
echos-judiciaires.com | echos-judiciaires.com | 30% | – | #3,294,377 | – |
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Fermentalg (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fermentalg
Complete news archive for Fermentalg
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fermentalg
Fermentalg was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Fermentalg is headquartered in Libourne, France. It is registered at Libourne, Nouvelle-aquitaine, France.
Fermentalg is a funded company, having raised a total of $30.3M across 5 funding rounds to date. The company's 1st funding round was a Series A of $7.21M, raised on Jan 2011.
Fermentalg has 64 employees.
Annual revenue of Fermentalg is $15.72M as on Dec 31, 2025.
Fermentalg was founded in 2005 in Libourne, France, within the biotechnology sector focused on microalgae cultivation. Biomass is produced through proprietary fermentation processes for applications in animal feed, human nutrition, and energy production. Twenty-six patents have been filed for these methods, and operations include over 30 fermenters with capacities ranging from 1 to 750 liters.
Fermentalg's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Fermentalg offers Vegan Omega 3, Natural Colors, Natural Antioxidants, Proteins for Aquafeed, and Proteins for Petfood.
Yes, Fermentalg is publicly traded on EURONEXT under the ticker symbol ALGAE.
Fermentalg has 10 investors. Key investors include Bpifrance, NextStage AM, Galia Gestion, Smalt Capital, and Sofiproteol.